Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilastine vs levocetirizine in chronic idiopathic urticaria (China)
CTR20181967Phase 3Completed
- Sponsor
- Menarini Group
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bilastine in chronic idiopathic urticaria (CIU), sponsored by Menarini Group. Started Nov 2018; status: completed.
02
Drugs
bilastine
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on CTR20181967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181967.